Suppr超能文献

胃肠道急性移植物抗宿主病中短链脂肪酸的研究进展

Research advances on short-chain fatty acids in gastrointestinal acute graft--host disease.

作者信息

Song Xinping, Lao Jing, Wang Lulu, Liu Sixi

机构信息

Shenzhen Children's Hospital, China Medical University, Shenzhen, Guangdong 518026, China.

Department of Hematology and Oncology, Shenzhen Children's Hospital, 7019 Yitian Road, Futian District, Shenzhen, Guangdong 518026, China.

出版信息

Ther Adv Hematol. 2024 Mar 28;15:20406207241237602. doi: 10.1177/20406207241237602. eCollection 2024.

Abstract

Gastrointestinal acute graft--host disease (GI-aGVHD) is a severe early complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). It has been shown that the intestinal microbiota plays a critical role in this process. As metabolites of the intestinal microbiota, short-chain fatty acids (SCFAs) are vital for maintaining the host-microbiota symbiotic equilibrium. This article provides an overview of the protective effect of SCFAs in the gastrointestinal tract, emphasizes their association with GI-aGVHD, and explores relevant research progress in prevention and treatment research.

摘要

胃肠道急性移植物抗宿主病(GI-aGVHD)是异基因造血干细胞移植(allo-HSCT)后严重的早期并发症。研究表明,肠道微生物群在这一过程中起关键作用。作为肠道微生物群的代谢产物,短链脂肪酸(SCFAs)对于维持宿主-微生物群共生平衡至关重要。本文综述了SCFAs在胃肠道中的保护作用,强调了它们与GI-aGVHD的关联,并探讨了预防和治疗研究中的相关进展。

相似文献

1
Research advances on short-chain fatty acids in gastrointestinal acute graft--host disease.
Ther Adv Hematol. 2024 Mar 28;15:20406207241237602. doi: 10.1177/20406207241237602. eCollection 2024.
3
Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis.
Semin Hematol. 2020 Jan;57(1):1-6. doi: 10.1053/j.seminhematol.2020.06.001. Epub 2020 Jun 11.
4
Human Amniotic Membrane-Derived Mesenchymal Stem Cells Prevent Acute Graft-Versus-Host Disease in an Intestinal Microbiome-Dependent Manner.
Transplant Cell Ther. 2024 Feb;30(2):189.e1-189.e13. doi: 10.1016/j.jtct.2023.11.005. Epub 2023 Nov 7.
7
The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease.
J Immunol Res. 2015;2015:145859. doi: 10.1155/2015/145859. Epub 2015 May 18.
8
Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.
Front Immunol. 2021 Mar 16;12:644982. doi: 10.3389/fimmu.2021.644982. eCollection 2021.
10

本文引用的文献

2
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease.
Cell Mol Immunol. 2023 Jun;20(6):613-625. doi: 10.1038/s41423-023-01022-z. Epub 2023 May 10.
7
Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease.
Oncologist. 2022 Aug 5;27(8):685-693. doi: 10.1093/oncolo/oyac076.
8
Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation.
Transplant Cell Ther. 2022 Mar;28(3):135-144. doi: 10.1016/j.jtct.2021.12.015. Epub 2021 Dec 24.
9
GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.
Front Immunol. 2021 Oct 28;12:753287. doi: 10.3389/fimmu.2021.753287. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验